NEW YORK and PORTLAND, Ore., Sept. 21, 2016 /PRNewswire/ -- Wellpartner (http://www.wellpartner.com), a leading provider of services to Covered Entities participating in the 340B Drug Pricing Program, announced it is deploying a Thought Leadership program to identify and analyze all of the key issues affecting the 340B industry. Information will accompany insight gained from over a decade of servicing clients.
"Empowering customers, through serving as a trusted source of meaningful 340B industry information, is integral to our efforts to perform at a genuine partnership level," said James Love, Wellpartner CEO. "Beyond delivering our industry-leading products and services, we serve as an advisor, and information will now be shared with a broad audience through Wellpartner's Thought Leadership program."
Based on Wellpartner's daily interaction with hundreds of Covered Entity clients, ranging from large DSH hospitals to small FQHCs, the company has a unique view of the 340B Program, from how it works, to how it should work. Wellpartner also understands the unique challenges that the Program imposes on Covered Entities and, most importantly, understands and fully supports the Program mission—to help Covered Entities stretch scarce federal resources, as far as possible, reaching more eligible patients and providing more comprehensive services.
"We look forward to sharing Wellpartner's Thought Leadership program with our clients", said Love. "We also invite our clients and others to provide us with feedback. From comments on our analyses to recommendations on future topics, we welcome all input."
Wellpartner is an industry-leading provider of 340B drug pricing program services. We also offer provider and patient-centric specialty pharmacy assistance through our URAC-accredited pharmacies. Our trusted 340B services are finely tuned toward optimizing our clients' programs including: industry-leading compliance; unlocking specialty scripts from exclusive networks; access to over 60,000 local, regional and national chain pharmacies and easy implementation of data interfaces. This helps us to achieve the same goal as our clients: to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. Today, hundreds of covered entities ranging from large DSH hospitals to small FQHCs trust Wellpartner to optimize their 340B programs and serve their patients. Wellpartner's experience is your advantage.
Mary Dannegger, Marketing Manager
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wellpartner-introduces-its-thought-leadership-program-300331332.html